Nurix Therapeutics (NRIX) Revenue (2019 - 2026)
Nurix Therapeutics (NRIX) recorded Revenue of $673.06 million in fiscal Q3 2026 (quarter ended Aug 31, 2026), compared with $7.89 million a year earlier.
Nurix Therapeutics (NRIX) Revenue (2019 - 2026) Analysis & Trends
On a TTM basis, Nurix Therapeutics' Revenue came in at $701.94 million as of Aug 31, 2026, up 738.8% year-over-year; for FY2025 (ended Nov 30, 2025), it was $83.98 million, up 54.0% from FY2024.
- Annual Revenue has a five-year compound annual growth rate of 36.3% (FY2020 to FY2025).
- Across earlier fiscal years, Revenue came in at $54.55 million in FY2024 (-29.1%), $76.99 million in FY2023 (+99.3%), $38.63 million in FY2022 (+29.8%) and $29.75 million in FY2021 (+66.9%).
- The fiscal Q3 2026 figure is the highest quarterly Revenue in data going back to fiscal Q3 2019.
- On a year-over-year basis, Revenue rose in three of the last seven quarters, with growth averaging 11.8%.
- Peak year-over-year performance for Revenue in the last five years was growth of 264.3% in fiscal Q2 2025, against a decline of 79.5% in fiscal Q2 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $9.04 million (Q2 2026), $6.25 million (Q1 2026) and $13.58 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 673.06 Mn |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 673.06 Mn |
| May 31, 2026 | 9.04 Mn |
| Feb 28, 2026 | 6.25 Mn |
| Nov 30, 2025 | 13.58 Mn |
| Aug 31, 2025 | 7.89 Mn |
| May 31, 2025 | 44.06 Mn |
| Feb 28, 2025 | 18.45 Mn |
| Nov 30, 2024 | 13.28 Mn |
| Aug 31, 2024 | 12.59 Mn |
| May 31, 2024 | 12.09 Mn |
| Feb 29, 2024 | 16.59 Mn |
| Nov 30, 2023 | 15.16 Mn |
| Aug 31, 2023 | 18.47 Mn |
| May 31, 2023 | 30.68 Mn |
| Feb 28, 2023 | 12.69 Mn |
| Nov 30, 2022 | 6.78 Mn |
| Aug 31, 2022 | 10.79 Mn |
| May 31, 2022 | 11.43 Mn |
| Feb 28, 2022 | 9.62 Mn |
| Nov 30, 2021 | 7.40 Mn |
Nurix Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=NRIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();